![](/img/cover-not-exists.png)
An Open-label, 2 x 2 Factorial, Randomized Controlled Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Placebo in Patients with Atrial Fibrillation and Acute Coronary Syndrome and/or Percutaneous Coronary Intervention: Rationale and Design of the AUGUSTUS Trial
Lopes, Renato D., Vora, Amit N., Liaw, Danny, Granger, Christopher B., Darius, Harald, Goodman, Shaun G., Mehran, Roxana, Windecker, Stephan, Alexander, John H.Language:
english
Journal:
American Heart Journal
DOI:
10.1016/j.ahj.2018.03.001
Date:
March, 2018
File:
PDF, 1.40 MB
english, 2018